• Home
  • News
  • Contact
  • #BIOPORT2022
BioportBioport
  • Schedule
  • Sponsors
  • Speakers
  • BioInnovation Challenge
  • Register
  • No menu assigned!

Novartis

  • 0 Shares Share
    0
  • 0

Novartis is a global healthcare company based in Switzerland that provides solutions to the evolving needs of patients worldwide.

Novartis focuses its business on three divisions with innovation power and global scale: pharmaceuticals, eye care and generics. These three divisions are supported by our research organization, the Novartis Institutes for BioMedical Research (NIBR), and a centralized services group, Novartis Business Services, to facilitate collaboration across our divisions, and drive efficiency and productivity gains.

We aim to develop innovative products in growing areas of healthcare. At the same time, we are expanding our presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.

Visit their website to learn more.

  • Previous Project
  • Next Project

CONFERENCE HOST: BIONOVA

#46 1344 Summer Street
Halifax, Nova Scotia
Canada B3H 0A8
Phone: 902-421-5705
Fax: 902-421-2733
Email: [email protected]

Recent News

  • NEWS RELEASE: BioNova Selects Eight Semi-Finalists to Participate in the 12th Annual BioInnovation Challenge August 25, 2022
  • Calling all Early-Stage Health and Life Sciences Companies in Atlantic Canada!  July 5, 2022
  • NEWS RELEASE: BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021 November 8, 2021
  • NEWS RELEASE: BioNova Selects Eight Semi-Finalists to Participate in the 11th Annual BioInnovation Challenge August 24, 2021
  • NEWS RELEASE: BioNova to Host the 20th Annual Regional BioPort Conference to Highlight the Innovation and Growth Potential of Health and Life Sciences July 12, 2021

Twitter

© 2016 BioNova

  • Home
  • Schedule
  • Sponsors
  • Speakers
  • BioInnovation Challenge
  • Register
  • News – Original
  • Contact